These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2521790)
1. Monoamine oxidase, brain ageing and degenerative diseases. Strolin Benedetti M; Dostert P Biochem Pharmacol; 1989 Feb; 38(4):555-61. PubMed ID: 2521790 [No Abstract] [Full Text] [Related]
2. Substrate specificity of human platelet monoamine oxidase B activity Parkinson's and Alzheimer's disease. Fitzgerald DH; Tipton KF; Anderson MC; Lawlor B Biochem Soc Trans; 1996 Feb; 24(1):63S. PubMed ID: 8674739 [No Abstract] [Full Text] [Related]
3. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Adolfsson R; Gottfries CG; Oreland L; Wiberg A; Winblad B Life Sci; 1980 Sep; 27(12):1029-34. PubMed ID: 7421397 [No Abstract] [Full Text] [Related]
4. [Monoamine oxidases of the brain and problems of central nervous system pathology (review)]. Gorkin VZ; Moskvitina TA Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1062-4. PubMed ID: 3929507 [No Abstract] [Full Text] [Related]
5. Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Oreland L; Gottfries CG Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):533-40. PubMed ID: 3797686 [TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase? Sandler M; Glover V; Clow A; Jarman J Adv Neurol; 1993; 60():238-41. PubMed ID: 8420141 [No Abstract] [Full Text] [Related]
8. The role of MAO in dopaminergic transmission. Riederer P; Konradi C; Youdim MB Adv Neurol; 1990; 53():149-53. PubMed ID: 2173368 [No Abstract] [Full Text] [Related]
9. [Characteristics of the disordered regulation of monoamine oxidase activity in pathological states and the regulatory role of the monoamine oxidases]. Gorkin VZ Vestn Akad Med Nauk SSSR; 1986; (8):8-13. PubMed ID: 3532612 [No Abstract] [Full Text] [Related]
17. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review). Cai Z Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484 [TBL] [Abstract][Full Text] [Related]
18. Brain and platelet monoamine oxidase in mental disorders 1. Schizophrenics and cycloid psychotics. Eckert B; Gottfries CG; Von Knorring L; Oreland L; Wiberg A; Winblad B Prog Neuropsychopharmacol; 1980; 4(1):57-68. PubMed ID: 7403345 [No Abstract] [Full Text] [Related]
19. Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. Jellinger K; Riederer P Adv Neurol; 1984; 40():199-210. PubMed ID: 6695595 [No Abstract] [Full Text] [Related]